These comments were presented before an expert panel organized by the Reagan-Udall Foundation. This expert panel was convened as part of the Reagan-Udall Foundation’s operational evaluation of the U.S. Food and Drug Administration’s (FDA) Center for Tobacco Products.
I want to thank the expert panelists for including this public dialogue as part of their evaluation of the U.S. Food and Drug Administration (FDA). I would also like to make it clear that my interest in this conversation is not to advocate for or against any particular product or company. My interest is in people, the individual human beings whose lives